Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study

Zaballa, María-Eugenia; Perez-Saez, Javier; de Mestral, Carlos; Pullen, Nick; Lamour, Julien; Turelli, Priscilla; Raclot, Charlène; Baysson, Hélène; Pennacchio, Francesco; Villers, Jennifer; Duc, Julien; Richard, Viviane; Dumont, Roxane; Semaani, Claire; Loizeau, Andrea Jutta; Graindorge, Clément; Lorthe, Elsa; Balavoine, Jean-François; Pittet, Didier; Schibler, Manuel

doi:10.1016/j.lanepe.2022.100547

research article

Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study

Zaballa, María-Eugenia

•

Perez-Saez, Javier

•

de Mestral, Carlos

more

December 1, 2022

The Lancet Regional Health - Europe

Name

1-s2.0-S2666776222002435-main.pdf

Type

publisher

Access type

openaccess

License Condition

CC BY

Size

538.92 KB

Format

Adobe PDF

Checksum (MD5)

ede00af652207d11913c735852e19b32